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Factor H is a regulatory glycoprotein of the complement sys-
tem. We expressed the three N-terminal complement control
protein modules of human factor H (FH1-3) and confirmed
FH1-3 to be theminimal unit with cofactor activity for C3b pro-
teolysis by factor I.We reconstructed FH1-3 fromNMR-derived
structures of FH1-2 and FH2-3 revealing an 105-A˚-long rod-
like arrangement of the modules. In structural comparisons
with other C3b-engaging proteins, factor H module 3 most
closely resembles factor B module 3, consistent with factor H
competingwith factor B for bindingC3b. FactorHmodules 1, 2,
and 3 each has a similar backbone structure to first, second, and
third modules, respectively, of functional sites in decay acceler-
ating factor and complement receptor type 1; the equivalent
intermodular tilt and twist angles are also broadly similar. Resem-
blance between molecular surfaces is closest for first modules but
absent in thecaseof secondmodules. SubstitutionofburiedVal-62
with Ile (a factor H single nucleotide polymorphism potentially
protective for age-relatedmacular degeneration anddense deposit
disease) causes rearrangements within the module 1 core and
increases thermal stability but does not disturb the interface with
module 2. Replacement of partially exposed (in module 1) Arg-53
by His (an atypical hemolytic uremic syndrome-linked mutation)
did not impair structural integrity at 37 °C, but this FH1-2mutant
was less stable at higher temperatures; furthermore, chemical shift
differences indicated potential for small structural changes at the
module 1–2 interface.
Complement factor H (FH)3 is a soluble multiple-domain
glycoprotein (155 kDa) that is abundant (500–800 g/ml) in
human plasma (1). It regulates the alternative pathway (AP) of
activation of the complement system, a key molecular compo-
nent of immune defense. Sequence variations in FH have been
linked to three complement-mediated diseases; dense deposit
disease (DDD, or membranoproliferative glomerulonephritis
type II), atypical hemolytic uremic syndrome (aHUS), and age-
related macular degeneration (AMD) (2–4). Factor H and five
FH-related proteins form a subgroup within the family of
homologous proteins encoded by the regulators of complement
activation (RCA) gene cluster (5–7). The other subgroup
includes C4b-binding protein -chain (C4BP), membrane
cofactor protein (MCP, CD46), decay accelerating factor (DAF,
CD55), and complement receptor type 1 (CR1, CD35).
Activation of the complement system via either the alterna-
tive or classical pathways involves a proteolytic cascade (8, 9).
During this process complement components are enzymati-
cally cleaved into active forms and surface-deposited. Deposi-
tion subsequently triggers destruction and immune clearance
and is accompanied by release of pro-inflammatory anaphyla-
toxins. The AP of complement is permanently switched on; if
left unchecked, a positive-feedback loop amplifies deposition of
activated components onto any nearby surface. Factor H con-
trols amplification via the AP both in fluid phase and selectively
on self-surfaces (10, 11), thereby helping to direct complement
toward its target, foreign or unwanted cells or particles. The
remaining RCA family members are membrane proteins (CR1,
DAF, and MCP) or act primarily on the classical pathway of
complement (C4BP).
Like the other RCA proteins, FH intervenes at the level of
enzymatically active bi- and trimolecular complexes called the
C3 and C5 convertases (C3b,Bb and C3b2,Bb, respectively, in
theAP). These assemble on surfaces during the activation proc-
ess and drive the proteolytic cascade by cleaving C3 andC5 into
active fragments. Via unknown mechanisms, FH competes
with factor B (FB) for binding to C3b, accelerates the irreversi-
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ble decay of the convertases into their components (C3b and
Bb), and acts as a cofactor for the factor I (FI)-mediated cleav-
age of C3b.
The 20 homologous domains that make up the whole of FH,
known as complement control protein modules (CCPs), are
each60 amino acid residues in length and stabilized by con-
served disulfide bonds (1, 12). Neighboring CCPs are linked by
sequences containing between three and eight residues (13).
Low-resolution structural studies suggest a “beads-on-a-string”
arrangement of CCPs within an elongated FH molecule that
may bendback on itself (14).Within FH,C3b-binding sites have
been mapped to CCPs 1–4 and CCPs 19–20 (15–18). A third
C3b-binding site was inferred to occupy CCPs 12–14 (17, 18).
The C-terminal C3b-binding site additionally binds polyanions
and acts as an anchor for attachment of FH to cell-surface
bound C3b (19–21). The N-terminal C3b-binding site on the
other hand is considered critical for engaging and disrupting
convertases given that a recombinant protein consisting of FH
modules 1–4 displays the full fluid-phase activity of FH and
retains a capability to accelerate decay of cell-surface bound
convertases (22–24). At least one single nucleotide polymor-
phism mapped to this region of FH has been linked to disease;
V62I has been suggested to be protective against AMD and
DDD (4, 25). Moreover, a mutation of Arg-53 to His was dis-
covered in a patient with aHUS (26).
Each RCA family member has a distinct functional profile
(27), but the structural basis for complement regulation
remains to be established. This is despite availability of experi-
mentally determined three-dimensional structures of C4BP
CCPs 1–2 (28), MCP CCPs 1–2 (29), DAF CCPs 1–4 (30), CR1
CCPs 15–17 (31), and the vaccinia virus complement control
protein (VCP) CCPs 1–4 (32), all of which correspond to com-
plete or partial functional sites within their respective parent
proteins (Fig. 1). The N terminus of
the principal soluble regulator of the
AP, FH, therefore provides an
attractive structural target. We
report the production of a function-
ally active recombinant fragment of
FH composed of CCPs 1–3 (FH1-3)
together with the three-dimen-
sional structure of FH1-3. We also
report on the structural conse-
quences of two disease-linked
sequence variations in this region.
EXPERIMENTAL PROCEDURES
Expression of Protein—The DNA
fragments encoding human FH res-
idues 20–142 for FH1-2, 84–206 for
FH2-3, and 20–206 for FH1-3
(native sequence numbering, i.e.
before cleavage of signal peptide)
were cloned into Pichia pastoris
expression vector pPICZ. These
clones have a valine at position 62
and, for the purposes of this study,
will be referred to as wild type. The
coding region of FH1-2 in pPICZwasmutated to the variants
FH1-2(H53) and FH1-2(I62) using the QuikChangeTM site-di-
rected mutagenesis kit (Stratagene). The expressed proteins
were directed to the secretory pathway by placing the Saccha-
romyces cerevisiae -factor secretion sequence upstream from
the coding sequence. FH like-1 (a splice variant containing
modules 1–7) was cloned into an insect cell expression system
and expressed and purified as described previously (33).
After transformation into P. pastoris strain KM71H, protein
was expressed and isotopically labeled in batches of 0.6 liters
(initial volume) of cell culture using a fermentor. Samples of
FH1-2 and FH2-3 were enriched with 98% 15N or with 13C
and 15N by providing (15NH4)2SO4 as the sole nitrogen source
and [13C]glucose, [13C]glycerol, and [13C]methanol as carbon
sources as previously described (34). Additionally, a 15N sample
of FH1-3was enrichedwith75% 2Hby using 95%D2O and 1%
methanol-d4 in the growth medium. After an induction period
of 4–6 days, cells were pelleted, supernatant was harvested and
diluted 5-fold in the presence of 5 mM EDTA and 1 mM phen-
ylmethylsulfonyl fluoride, and the pHwas adjusted to 4.0. Puri-
fication of all three constructs was achieved by cation-exchange
chromatography (SP Sepharose Fast FlowTM Sigma-Aldrich)
followed by reverse phase high performance liquid chromatog-
raphy (SupelcoDiscoveryBIOWide PoreC5 column, Supelco
Inc., PA). The resulting peak fractions were lyophilized. N-ter-
minal sequencing confirmed the identity of the protein con-
structs as well as the presence of anN-terminal cloning artifact,
EAEAAG, left over from incomplete processing of the -factor
secretion signal by the aminodipeptidase Ste13. Mass spec-
trometry confirmed the predicted sequence and the expected
oxidation state of all cysteines (as contributors to disulfide
bonds). Yields of purified protein were in the region of 1 mg of
protein per g of wet cells.
FIGURE 1. Sequence alignment for some CCPs of known three-dimensional structure. The three blocks of
sequences represent first, second, and third modules of functional sites. FB CCP 1 and CR1 CCP 17 have
insertions comparedwith other sequences as indicated. Conservation of residues in four ormore neighboring
sequences is indicated by shading. Residues that lie in-strands are underlined, and corresponding regions are
assigned numbers that reflect the occurrence of up to eight -strands (as identified by STRIDE (77)) in some
examples of this module family. Bold font indicates a residue considered to be functionally critical on the basis
of mutagenesis; black arrows indicate such residues in DAF that are conserved in FH; white arrows indicate
residues critical for C3b interaction in FB CCP 3 conserved in FH CCP 3. Filled squares indicate exposed side
chains, and half-filled squares correspond to partly exposed side chains in FH (as identified by GETAREA (57)).
Arg-53 and Val-62 are indicated in italics, and hv loop indicates the position of the hypervariable loop.
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Determination of Complement-regulating Activity—Cofac-
tor activity was initially determined using an end point fluid-
phase cofactor assay. Molar equivalent amounts (1 M) of con-
structs FH1-2, FH2-3, and FH1-3were added to 5g (1.8M) of
purified complement C3b mixed with 2 g (1.4 M) of FI (both
from Comptech) in a total volume of 15 l. A negative control
where no FH constructs were present was also included. After
incubation for 1 h at 37 °C, SDS-containing sample buffer
including the reducing agent dithiothreitol was added, and the
reactions were then heat-inactivated. The samples were sub-
jected to SDS-PAGE to detect the extent of proteolytic cleavage
of C3b -chain by FI. To obtain a semiquantitative estimation
of FH1-3 activity, a concentration titration cofactor assay was
performed using the above assay conditions on full-length FH
and FH1-3 at a series of molar-equivalent concentrations in a
total reaction volumeof 15l and incubated for 10min at 37 °C.
The decay acceleration assay was performed on FH1-3, FH-
like-1, and FH as previously described (20).
Data Collection and Processing—The addition of free L-Arg
and L-Glu was previously reported to increase long-term stabil-
ity and solubility of concentrated protein NMR samples (35).
The present study utilized deuterated versions (L-Arg-d7 and
L-Glu-d5) to prevent their signals dominating 13C,1H- resolved
experiments.
Standard suites of NMR spectra (36) were acquired on
Bruker AVANCE 600 and 800MHz spectrometers using 5-mm
triple-resonance probes. Data for resonance assignments were
acquired at 37 °C on 1mM 13C,15N FH1-2, 2mM 13C,15N FH2-3,
and 0.6 mM 2H,15N FH1-3 in 20 mM potassium phosphate,
0.05% (w/v) NaN3, 10% (v/v) D2O, 50 mM arginine-d7, 50 mM
glutamate-d5 at pH 6.2. 15N-Edited nuclear Overhauser effect
spectroscopy-HSQC (NOESY-HSQC) (37) experiments were
acquired on all constructs at 800MHzwithmixing times of 100
ms. 13C-EditedNOESY-HSQC (38) experiments were acquired
at 800MHz for FH1-2 and FH2-3 with mixing times of 100 ms.
Steady-state (1H,15N) nuclear Overhauser effects (NOEs) (39)
were measured at 600 and 800 MHz and were calculated from
the ratio of the intensities of the cross-peaks in the reference
spectra to those recorded with saturation of the 1H signal.
Additionally, a 1H,15N-states time-proportional phase incre-
mentation transverse relaxation-optimized spectroscopy spec-
trum (40) with watergate was acquired for FH1-3 at 800 MHz.
Subsequently, the FH1-2 and FH2-3 samples were aligned in
12 mg/ml Pseudomonas filamentous phage (Profos, Regens-
burg,Germany) formeasurements of residual dipolar couplings
(RDCs); buffer conditions were kept identical to those used for
NOE measurement. The degree of alignment was monitored
from the splitting of the 2H signal, 6.2 Hz for FH1-2 at 600MHz
and 7.1Hz for FH2-3measured at 800MHz. 1DNH (41), 1DCH
(42), and 1DCC (43) RDC couplingsweremeasured for aligned
and unaligned samples of FH1-2 and FH2-3. The RDCs from
residues deemed flexible based on relaxation data criteria were
not used in the structure calculations (44).
NMR data were processed using the Azara suite of programs
provided by Wayne Boucher and the Department of Biochem-
istry, University of Cambridge, UK. Maximum entropy recon-
struction was used for the F1 and F2 dimensions of the three-
dimensional experiments. The RDC data were analyzed using
an in-house macro developed for the Collaborative Computing
Project for the NMR community Analysis software (45). Relax-
ation data were analyzed using the rates analysis function pro-
vided in the Analysis software (45). Analysis of NMR relaxation
data and scrutiny of FH1-2 and FH2-3NOESY spectra provided
no evidence of non-transient self-association.
Resonance Assignment and Structure Calculation—Pro-
cessed spectra were viewed, and nuclei were assigned using
Analysis (45). For example, 96 and 98% of observable pro-
tons were assigned within FH1-2 and FH2-3, respectively.
Resolved peaks in 15N NOESY and 13C NOESY spectra were
picked, and where possible, the root resonances were assigned
unambiguously. All proline residues were defined as trans
based on chemical shift differences between C and C reso-
nances (46) and observation of appropriate strong NOE cross-
peaks. A list of chemical shifts and a set of largely unassigned
NOESY spectrawere supplied as input forCYANA2.1, an auto-
mated structure-calculation software (47). The disulfide link-
ages were inferred from the proximity and geometry of Cys side
chains in an initial set of structure calculations using CYANA
2.1 that did not incorporate disulfide bonds. Hydrogen bonds
were inferred on the basis of a series of 15N HSQC spectra
recorded on lyophilized samples resuspended in 99.96% D2O
(Sigma-Aldrich) over a time-course of 2 h with 15-min inter-
vals. No significant difference in the protected amides signals
was observed after 1 h. Hydrogen-bond derived distance con-
straints were then created for protected protons possessing a
feasible proton-accepting partner, as judged from first-round
structure calculations in CYANA 2.1. A seven-cycle routine of
target function minimization was subsequently performed
using the combined automated NOE assignment and structure
determination module within CYANA 2.1. The upper-limit
distance constraints, 2722 for FH1-2 and 2733 for FH2-3, gen-
erated fromCYANA 2.1 were converted to the Crystallography
and NMR System (CNS) format (48) using FormatConverter
(45). These constraints were incorporated into a final round of
structure calculations, performed using CNS, during which the
RDC constraints, 91 for FH1-2 and 169 for FH2-3, were incor-
porated into the final stages of refinement by including a
TENSO energy term (49) with a harmonic potential. A lack of
NOEor RDCviolations and the low rootmean square deviation
(r.m.s.d.) for backbone atoms (Table 1) confirmed the three-
dimensional structure of each protein is well defined by exper-
imental data. Overall quality as assessed byWHAT IF (50) and
favorable Ramachandran statistics (51) was checked for consis-
tency with a high resolution structure. The FH1-2(H53) model
was created on the basis on the closest-to-mean FH1-2(R53)
NMR structure employing the side-chain replacement pro-
gram, SCWRL Version 3 (52, 53).
Deriving the Structure of the Triple Module Construct FH1-3—
The structure of CCP 2 was found to be very similar in both
FH1-2 and FH2-3. The largest context-dependent structural
differences occur in loops located close to the C terminus of
CCP 2, adjacent to CCP 3. On the other hand, the structures of
the loops of CCP 2 adjacent to its N terminus and the CCP 1–2
interface appear context-independent. This observation was
corroborated by a comparison of chemical shifts between the
twomodule pairs (not shown). A 15NHSQC spectrum and 15N
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HSQC transverse relaxation-optimized spectroscopy spectrum
of the FH1-3 construct were recorded on a 0.6 mM sample of
2H,15N FH1-3 in 20mM potassium phosphate, 50 mM arginine-
d7, 50 mM glutamate-d5 at pH 6.2. The spectra were compared
with those of the two pairs, FH1-2 and FH2-3, to assess the
degree of conservation in chemical shifts (supplemental Fig. 1).
This subsequently provided a basis for rational selection ofCCP
2 residues from each module-pair structure to use in creating
the template for the modeling procedure (Fig. 2, C and D). In
this regard, carewas taken to preserve the structure of the loops
involved in the intermodular junctions, as identified from the
module-pair structures using the Protein Interaction Calcula-
tor (54) server. The closest-to-mean structures onCCP2 for the
pairs were then superimposed on their mutual CCP 2, and
appropriate complementary segments of CCP 2were deleted to
create the template. Modeler 9v1 (55, 56) was used to recon-
struct 20 models of FH1-3, and the one with the lowest objec-
tive function score was selected as the representative model.
The solvent-accessible surface area for exposed side chains in
FH1-3 and buried surface areas at bimodular interfaces were
calculated using GETAREA version 1.1 (57). Intermodular tilt,
twist, and skew angles for FH1-2 and FH2-3 were calculated
using the same protocol as previously described (13, 58). Visu-
alization of structures and generation of figures was performed
using PyMOL (59).
RESULTS
FH1-3, the Minimal Unit Capable of Cofactor Activity—To
determine theminimal unit of FH capable of serving as a cofac-
tor for FI-catalyzed proteolysis of C3b, the constructs FH1-2,
FH2-3, and FH1-3, expressed and purified from P. pastoris,
were tested for activity in a SDS-PAGE based cofactor assay
(Fig. 3A). This experiment demonstrated that FH1-3 displayed
measurable cofactor activity, whereas the pairs FH1-2 and
FH2-3, at molar equivalent concentrations, did not. An assay
(Fig. 3B) in which activity was measured as a function of the
amount of cofactor indicated that about 10-fold more FH1-3
than full-length FH is required to achieve a similar extent of
C3b cleavage, reflecting a contribution from the other modules
of FH. Thus, FH1-3 represents the minimal unit capable of
cofactor activity and is a worthwhile structural target. We also
assayed FH1-3 for decay acceleration activity (data not shown)
and compared it to full-length FH and to FH-like 1. We could
not detect any activity of FH1-3 at a concentration 100-fold
higher that the concentration of FH or6-fold higher than the
concentration of FH like-1, required to release 50% of Bb from
cell-surface-attached convertase.
Structure Determination of FH1-3—We elected to recon-
struct the three-dimensional structure of FH1-3 computation-
ally from the structures of FH1-2 and FH2-3 rather than deter-
mine directly the structure of FH1-3. This decisionwas dictated
by issues of yield, solubility, and spectral quality. Similar prob-
lems were encountered in a study of a triple-CCP module seg-
ment of CR1 (31).
Using 13C,15N-labeled samples of recombinant FH1-2 and
FH2-3, conventional heteronuclear NMR experiments led to
good-quality structure determinations (Table 1). The ensem-
bles of lowest energy FH1-2 and FH2-3 structures displayed in
Fig. 2 are consistent with 2722 and 2733 upper-limit distance
constraints, respectively. Sets of 20 and 8 NOE-derived inter-
modular distance constraints along with 91 and 169 RDC con-
straints help define the 1-2 and 2-3 module-module interfaces,
respectively. The angles (13, 58) that describe the intermodular
orientations of each member of the ensemble are summarized
in Table 1 and graphed in Fig. 4.
Fig. 2 shows the lowest energy structures of FH1-2 andFH2-3
overlaid on the backbone atoms of CCP 2, with a low r.m.s.d. of
0.78 Å. A comparison, taking advantage of a partial backbone
assignment of FH1-3, revealed no evidence to suggest that the
presence of CCP 1 affects the chemical shifts of residues at the
CCP 2–3 interface nor that the presence of CCP 3 perturbs
chemical shifts in the CCP 1–2 interface (supplemental Fig. 1).
It was, therefore, legitimate to derive the structure of FH1-3 by
computationally concatenating the twomodule-pair structures
TABLE 1
Structural statistics for the lowest energy structures
FH1-2 FH2-3
Number of lowest energy structuresa,b 30 29
Upper limit distance constraints
Intraresidue 563 562
Sequential 837 789
Intermediate range (2 i j  4) 323 337
Long range (i j 4) 999 1045
Total 2722 2733
Intermodular 20 8
Module 1 to linker 58
Module 2 to linker 48 57
Module 3 to linker 35
Hydrogen bonds 20 16
Residual dipolar couplings
1DNH 55 751DCC 36 591DCH N/Ac 35
Root mean square deviations (residues from CysI to
CysIV of each module)
All heavy atoms 1.25 1.28
Backbone atoms C, N, CO
Module 1 0.52
Module 2 0.69 0.32
Module 3 0.96d
All modules 0.92 0.90
Skew, twist, and tilt angles (°)
Skew
Minimum 236 46
Maximum 280 145
Mean 259 91
S.D. 12 19
Twist
Minimum 163 131
Maximum 185 150
Mean 173 141
S.D. 6 5
Tilt
Minimum 15 6
Maximum 35 24
Mean 23 15
S.D. 5 4
Ramachandran assessment (%)
Most favored 76.4 79.3
Additionally allowed 20.9 19.6
Generously allowed 1.2 0.8
Disallowed 1.5 0.3
Coarse packingWHAT IF score 1.574 1.254
Buried surface area of intermodular junction (Å2) 549 517
Buried surface area of intermodular junction
in FH1–3 (Å2)
534 509
a Less than two NOE violations above 0.5 Å for each structure.
b PDB accession codes 2RLP and 2RLQ respectively.
cNot available due to poor spectral quality.
dHigh value due to the flexible and ill-defined hypervariable loop.
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ensuring that the appropriate module-module interfaces and
orientations are retained.
The Three Modules of FH1-3 Are Organized in a Rod-like
Arrangement—The three compactly folded, oblate CCPs that
comprise FH1-3 are arranged in an end-to-end rod-like confor-
mation spanning105 Å from tip to tip (Fig. 2). The variation
in intermodular angles among the ensemble of calculated struc-
tures likely reflects some limited flexibility between modules.
There are several exposed apolar residues in each module (see
Fig. 1), but inspection of the overall surface of FH1-3 revealed
no extensive hydrophobic patches. A representation of the elec-
trostatic surface of FH1-3 demonstrates that CCP 1 exposes
more extensive and prominent electro-positive regions (Fig. 5)
than the other modules, and this is particularly evident toward
its interface with CCP 2.
Five predominantly extended stretches of residues con-
nected by turns or loops run back and forth in approximate
alignment with the long axis of each of the three CCPmodules.
These form -strands and small -sheets varying between the
modules in number and extent (Fig. 1) and held together by a
compact hydrophobic core plus two disulfide bonds. For the
purposes of cross-reference and further discussion, regions
within the FH modules were assigned numbers that reflect the
occurrence of up to eight -strands in other examples of this
module family (see Fig. 1). The N-terminal CCP of FH is dis-
similar from the other two (C r.m.s.d. of 3.1 and 3.0 Å versus
CCP 2 and 3, respectively), whereas CCPs 2 and 3 overlay with
a C r.m.s.d. of 1.8 Å even though the highest level of sequence
identity is betweenCCPs 1 and 2 (Table 2). A stretch of residues
before strand 3 (see Fig. 1) has previously been called the hyper-
variable loop (27); in CCP 3 this has 1H,15N NOE intensities
lower than 0.5 and, thus, is less well structured than the hyper-
variable loops of CCP 1 and CCP 2. Otherwise, heteronuclear
NOEs for residues in all three modules and in the linking
sequences between them are predominantly uniform (data not
shown).
The elongated nature of FH1-3 reflects small intermodular
tilt angles (see Fig. 4, G andH). Twist angles on the other hand
are large so that the hypervariable loops, labeled in Fig. 2, of
modules 1 and 3 project from the same face of the FH1-3 struc-
ture (module 2 does not possess a prominent hypervariable
loop due to a deletion in this region; see Fig. 1). Each of the two
intermodular interfaces is stabilized by H-bonds between the
third linker residue and the extremities of long strands 4 within
the adjacent modules; i.e. between the amide of linker residue
Arg-83 or Val-144 and the carbonyl of Gly-55 or Gly-117 (both
in 4–5 loops), respectively, and between the carbonyl of Arg-83
or Val-144 and the amide of Tyr-106 or Phe-170 (both in 3–4
loops), respectively. The CCP 1-CCP 2 andCCP 2-CCP 3 inter-
faces bury 549 and 517 Å2 of surface area, respectively. In each
case the start of strand 5 of the preceding module contributes
hydrophobic portions of side chains (e.g.Tyr-56 fromCCP 1) to
FIGURE 2. NMR-derived structures of FH1-2 and FH2-3 and reconstructed FH1–3. A, backbone representations showing separate ensembles of FH1-2
(cyan) and FH2-3 (magenta) structures, each superimposed on the C atoms of their respective CCP 2s. B, backbone representations showing both the
ensembles superposed on theirmutual CCP 2s (C r.m.s.d. 0.78 Å).C, schematic representation of the structure of FH1-3 derived from structures of overlapping
pairs and showing the boundaries of the FH1-2 and FH2-3 structures used as templates in Modeler 9v1 (55, 56). D, orthogonal view of the schematic
representation in C.
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a hydrophobic cluster along with the alkyl segments of linker
side-chains (e.g. Lys-82 and Arg-83 in the CCP 1-CCP 2 linker)
and side chains from the 3–4 loop and the 6–7 loop (e.g. Thr-
131 in CCP 2) of the next module.
Structural Consequences of Disease-linked Sequence Varia-
tions V62I and R53H—We inspected the structure of FH1-3 to
ascertain the likely structural consequences of disease-linked
sequence variations. The side-chain of Val-62 is completely
buried toward the C-terminal end of the hydrophobic core of
CCP 1. Replacementwith isoleucine occurs as a result of a com-
mon single nucleotide polymorphism that appears to be pro-
tective against AMD and DDD (4, 25). This insertion of an
additional methylene group into the core of a small globular
domain could have profound effects on its folding and stability
(60). To address this issue, we expressed a 15N-labeled NMR
sample of the V62I variant of FH1-2 (termed FH1-2(I62) to
distinguish it from the original sample of FH1-2(V62)) in
P. pastoris and collected a 15N HSQC spectrum (supplemental
Fig. 2A). The overall similarity of this spectrum to the 15N
HSQC spectrum of FH1-2(V62) proves that both CCPmodules
in FH1-2(I62) fold correctly. Further analysis investigatedmore
subtle structural differences between the two variants. On the
basis of comparisonwith the FH1-2(V62) 15NHSQC spectrum,
combined 15N and 1H chemical shift perturbation values (61)
were calculated for FH1-2(I62) and plotted against residue
number; amides exhibiting the largest changes in chemical
shifts were then highlighted on the FH1-2 structure (Fig. 6).
Notably, differences are exclusive to CCP 1, and there are neg-
ligible changes in CCP 2 chemical shifts. Differences are wide-
spread throughout CCP 1 but centered on residue 62, as
expected. The cross-peak corresponding to the amide of Tyr-
50, H-bonded to the carbonyl of residue 62, exhibits one of the
biggest changes in amide chemical shift. Other differences in
chemical shift are attributable to small rearrangements in the
hydrophobic core to accommodate the extra methylene group
of Ile-62. The exchange rates with solvents of amide protons
reflects the extent of hydrogen-bonded secondary structure
and conformational flexibility. Observation of slowly exchang-
ing amides, i.e. those still observable after 1 h, indicates that
FH1-2(I62) is at least as rigid in this respect as FH1-2(V62)
(supplemental Fig. 3). A series of 15NHSQC spectra collected at
increasing temperatures demonstrates that FH1-2(I62) is
slightly more thermally stable than FH1-2(V62) (supplemental
Figs. 2, A–C, and 4).
Mutation of Arg-53 to histidine has been found in FH of an
aHUS patient (26). According to a sequence alignment (Fig. 1),
this residue is conserved in several modules that represent the
N-terminal CCPs of functional sites in RCAs. From the struc-
ture of FH1-3 it is apparent that the guanidyl group of this side
chain is exposed on the side of CCP 1, but most of its long alkyl
chain is buried. In the structure of thewild type the side chain of
Arg-53 lies alongside that of Tyr-56 (Fig. 7). The latter is a
strictly conserved hydrophobic residue of CCP 1 that is also
proximal to several residues of CCP 2, including Thr-131 and
(the well conserved) Tyr-106. The question thus arises when
these contacts are disrupted by replacement of Arg-53 with a
histidine residue, Does CCP 1 still adopt a stable folded struc-
ture? As with FH1-2(I62), the aHUS-associated mutant FH1-
2(H53) was expressed and labeled with 15N. The 15N HSQC
spectrum of FH1-2(H53) at 37 °C (supplemental Fig. 5A) is
clearly that of a fully folded protein, very similar in structure to
FH1-2 and consistent with the outcome of a computational
model of the mutant protein (Fig. 7). Further examination
revealed that cross-peaks in NMR spectra for the FH1-2(H53)
amides of residuesHis-53 andGly-55were untraceable (residue
54 is a proline), whereas cross-peaks for the amides of residues
Lys-51, Cys-52, and Tyr-56 had substantially altered chemical
shifts. All of these residues are in the 4–5 loop of CCP 1 that
extends toward CCP 2 andmakes contact with the CCP 1-CCP
2 linker (Fig. 4). Cross-peaks corresponding to residues in the
adjacent region of CCP 1 (Asn-29—Ile-32), whose side chains
partly bury the alkyl side-chain of Arg-53 in the wild-type,
undergo large changes in chemical shift. These two loops
account for most of the chemical shift differences between
mutant and wild type within CCP 1. Interestingly, the amide
chemical shifts of Gln-81 in the intermodular linker of FH1-
2(H53) are also perturbed with respect to the wild-typemodule
pair as are the amides of two CCP 2 residues, Tyr-106 and
Thr-131; both of these lie close to Tyr-56 within the interface
between CCPs 1 and 2. Slowly exchanging amides in FH1-
2(H53) were found to be fewer in number than in FH1-2(V62)
or FH1-2(I62); this observation is consistent with a greater
degree of conformational flexibility in the mutant (supplemen-
FIGURE 3. Assays of cofactor activity for factor I-catalyzed cleavage of
C3b. Inferred identities of Coomassie-stained protein bands on SDS-PAGE
gels are indicated.MWM, molecularweightmarkers.A, results of an endpoint
C3b cofactor assay (excess C3b and FI in the absence (lane 2) and presence of
1 M FH1-2 (lane 4), 1 M FH2-3 (lane 5), and 1 M FH1-3 (lane 6). Molecular
weight markers are in lane 1. B, C3b cofactor assay with excess FI and C3b in
the presence of FH at 0, 0.84, 2.53, 7.6 nM (lanes 1–4) or FH1-3 at 0.84, 2.53, 7.6,
22.8, 68.4, and 205 nM (lanes 5–10).
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FIGURE4.Structural comparisonof FH1-3withDAF-(1–4) andCR1-(15–17). Schematic representations are drawn in PyMol: DAF-(1–4) (green), CR1-(15–17)
(blue), andFH1-3 (CCP1, red; CCP2,magenta; CCP3,orange). Overlays, performedon the cysteineC atoms, are as follows:A, DAFCCP2andFH1-3CCP1;B, DAF
CCP 3 and FH1-3 CCP 2; C, DAF CCP 4 and FH1-3 CCP 3; D, CR1 CCP 15 and FH1-3 CCP 1; E, CR1 CCP 16 and FH1-3 CCP 2; F, CR1 CCP 17 and FH1-3 CCP 3. Plots
to showcomparisonof intermodular angles (mean1S.D. for theensemble in each case) between first and secondmodules (G) and secondand thirdmodules
(H) of the functional sites within FH, DAF, and CR1 (site 2).
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FIGURE 5. Comparison of electrostatic surfaces of FH1-3 with DAF-(1–4) (A) and CR1-(15–17) (B). The surfaces were generated using the Adaptive
Poisson-Boltzmann Solver (78) plug-inwithin PyMol (using the PARSE (79) parameter setwith the nonlinear formof the Poisson-Boltzmannequation, a protein
dielectric constant of 20, solvent dielectric constant of 80, solvent ion radius of 1.4 Å, temperature 310 K, and assumed ion concentration of 100 mM). Red is
negative charge, and blue is positive chargewithin a range of5/5 kT (k Boltzmann’s constant, T absolute temperature). The orientation of FH1-3 is the
same as in Fig. 2D. The other structures were orientated by superposing DAF CCP 2 (A) or CR1 CCP 15 (B) on FH CCP 1 and then transposing.
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tal Fig. 3). A series of 15N HSQCs recorded at increasing tem-
peratures suggested that FH1-2(H53) reversibly loses its
compactly folded nature at a lower temperature than either the
Val-62 or Ile-62 variants (supplemental Fig. 5, A–C). Module 1
appears to be more strongly affected as a result of the R53H
mutation, but both modules lose thermal stability (supplemen-
tal Fig. 4). Unlike FH1-2(V62) or FH1-2(I62), FH1-2(H53)
shows some loss of spectral intensity over the 37–45 °C range.
DISCUSSION
Extended and Twisted Three-CCP Segments Are Minimal
Functional Units of RCAs—Pure properly folded protein con-
sisting of the three CCPs at the FH N terminus (i.e. FH1-3) has
cofactor activity for FI-catalyzed cleavage of C3b, although
10-fold more FH1-3 compared with full-length FH is required
to achieve the same level of activity. This observation supports
previous studies of material secreted from Chinese hamster
ovary cells (22) but disagrees with a negative result for a version
of FH1-3 expressed in a baculovirus system (23). Triple-CCP
module segments of CR1 (i.e. CCPs 1–3, 8–10, and 15–17) are
also functionally active, although, as in FH, neighboring mod-
ules boost these activities (62). Three consecutive modules of
C4BP (CCPs 1–3) (63), MCP (CCPs 2–4) (64), and VCP
(CCPs 1–3 and 2–4) (65) likewise constitute minimal func-
tional sites. Thus, three CCP modules appear to be generally
required to bind C3b/C4b in the process of preparing these
molecules for cleavage by FI. We could not detect decay-accel-
erating activity for FH1-3 in a cell-surface assay but note that in
the case of DAF, three modules (CCPs 2–4) are necessary and
sufficient to engage with C3b,Bb (66) and accelerate its decay.
The simplest interpretation of the fact that FH has100 times
more decay accelerating activity (and FH-like 1 (effectively
CCPs 1–7 of FH) is at least 6 times more active) is that each of
the GAG binding CCP modules of factor H, including CCPs 7
and 20, contribute strongly to the ability of FH to bind to the cell
surface in the vicinity of the convertase, and CCPs 19 and 20
provide additional affinity for cell surface-bound C3b. It
remains possible that FH1-3 plays a principal role in the dis-
mantling of the convertase once FH is anchored to the surface,
but based on previous reports of baculovirus-expressed FH[1–
4] having measurable decay accelerating activity (24), it seems
likely that CCP 4 of FH also contributes to direct engagement
with the convertase. It is notable that the proenzyme FB also
contains three CCPmodules. These are stowed away in a com-
pact fashion but loosely associated with the remainder of FB
before the encounter with C3b (67), whereupon they presum-
ably swing out and engage with C3b; subsequently the FB CCPs
are cleaved and dissociate, leaving active C3 convertase
(C3b,Bb). In summary, three-CCP module segments of com-
plement proteins represent functional units whose structures
can be usefully compared and contrasted.
The overall structure of FH1-3 is highly extended (105Å in
length) like the structures of CR1-(15–17) (118 Å) and CCP
modules 2–4 (112Å) of the DAF-(1–4) crystal structure (Fig.
4, A–F) but unlike the compact arrangement of the three FB
CCPs. Agreement between the NMR-derived FH1-3 structure
and the same modules within a best-fit model of FH modules
1–5 built on the basis of small-angle x-ray scattering data and
homology (68) is poor (12.6 Å for C). Indeed, in the most
favored scattering-based model, modules 1–3 form a bent
rather than a straight structure. Note, however, that better
agreement in terms of the extended nature of modules 1–3 is
obtained when comparing the NMR-derived FH1-3 structure
with “model 11” from the deposited ensemble of modeled
structures that reportedly fit with the scattering data. This
implies that CCPs 4 and 5 must be highly tilted relative to one
another and to CCP 3 in an otherwise straight structure of FH
modules 1–5 to be consistent with both NMR spectra and cur-
rent interpretation of the small-angle x-ray scattering data.
Tilt angles within the functional sites of FH, CR1, and DAF
are uniformly small, whereas twist angles between first and sec-
ondmodules are close to 180°, and twist angles between second
and third modules are between 90 and 135° (Fig. 4, G and H).
The relatively small surface areas buried between neighboring
CCP modules (500 Å2) have similar values in FH1-3, DAF,
and CR1-(15–17) (13). These observations suggest that a
twisted, end-to-end arrangement of CCPs capable of spanning
non-proximal subsites within the convertase is crucial for func-
tion. Conformational mobility among the multiple domains of
C3b is probable (69–72), and it is conceivable that FH shares
with CR1 (and MCP) the ability to bind and stabilize a domain
rearrangement that renders the first cleavage site in C3b acces-
sible by FI; interactions of these RCAs with FI are also likely.
TheCCPs of the viralmimic of RCAs, VCP, aremore tilted than
their mammalian equivalents, bury more surface area between
them (800–900 Å2 in two of the interfaces (13)), and produce
less-extended functional sites (CCPs 1–3 measure 95 Å and
CCPs 2–4 measure91 Å in length).
FH CCPs 1–3 Structurally Resemble Equivalently Positioned
CCPs in DAF and CR1—The program Combinatorial Exten-
sion (73) was used to structurally align and calculate C
TABLE 2
Structure and sequence pair-wise similarities between FH and other
RCA-CCPs of known structure
Domain boundaries considered from one residue before CysI to three residues after
CysIV (where available). Values on the left-hand side specify C r.m.s.d. values in
Angstroms (Å) Values in parentheses represent the structural alignment lengths in
terms of the numbers of C atoms for which the r.m.s.d. values were calculated.
Values in italics on the right-hand side represent pair-wise percentage (%) sequence
identities calculated using the Percentage Identity Matrix option under ClustalX
(80).
Factor H modules
RCA-CCP (PDB code (81)) FH1 FH2 FH3
FH 1 (2RLP)
FH 2 (2RLQ) 3.12 (59); 27
FH 3 (2RLQ) 3.00 (54); 22 1.80 (55); 20
FB 1 (2OK5) 4.13 (64); 20 2.34 (55); 19 2.04 (51); 32
FB 2 (2OK5) 3.35 (60); 20 2.20 (57); 24 1.80 (58); 25
FB 3 (2OK5) 3.38 (58); 23 1.91 (57); 23 1.30 (56); 26
C4BP 1 (2A55) 2.23 (60); 27 3.48 (69); 24 3.24 (61); 19
C4BP 2 (2A55) 3.22 (58); 22 1.81 (57); 31 1.70 (57); 24
CR1 15 (1GKN) 1.98 (58); 26 3.03 (59); 20 2.76 (55); 18
CR1 16 (1GKN) 3.38 (58); 24 1.57 (58); 28 1.67 (57); 24
CR1 17 (1GKG) 2.74 (58); 26 2.31 (58); 36 2.12 (57); 32
DAF 1 (1OK3) 2.48 (60); 22 2.54 (59); 15 2.59 (59); 17
DAF 2 (1OK3) 2.22 (61); 31 2.92 (60); 21 2.80 (59); 20
DAF 3 (1H03) 3.31 (58); 22 1.59 (58); 29 1.54 (57); 34
DAF 4 (1H03) 2.68 (58); 28 1.91 (57); 25 1.63 (58); 31
MCP 1 (2CKL) 2.56 (60); 23 2.73 (58); 20 2.73 (58); 22
MCP 2 (2CKL) 3.32 (53); 27 1.77 (59); 36 1.63 (56); 34
VCP 1 (1G40) 3.41 (61); 27 3.09 (59); 24 2.82 (60); 21
VCP 2 (1G40) 3.33 (58); 22 2.44 (57); 39 2.04 (56); 28
VCP 3 (1G40) 2.79 (58); 30 2.57 (58); 30 2.47 (56); 35
VCP 4 (1G40) 3.06 (58); 25 2.21 (55); 21 2.29 (58); 38
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r.m.s.d. values (Table 2) for each of CCPs 1, 2, and 3 of FH
versus other CCPs of known structure that interact with
C3/C4 or C3b/C4b.
There is a striking overlay of the backbones of FH CCP 3 and
FB CCP 3 (1.3 Å over 56 C atoms). Moreover FB CCP 3 resi-
dues known to be critical for interaction with C3b are con-
served in FH CCP 3 (Fig. 1). The other CCPs of FB and FH are
less similar, suggesting that competition by FH for FB binding
to C3b is likely a consequence of a shared binding site on C3b
for their respective third modules. It is probable that module 4
extends the footprint of FH on C3b, enhancing affinity and
helping to explain the relatively poor complement regulatory
activity of the three-module construct.
Comparison of backbone structures shows that the N-termi-
nal CCP of FH ismore similar to the firstmodules of other RCA
functional sites than it is to their second and third modules.
Similarity is highest in the cases of the first CCP in site 2 of CR1,
i.e. CCP 15, and the first CCP of the DAF functional site, i.e.
CCP 2 (Table 2). Not only does the FH CCP 1 backbone super-
imposewell on the backbones of thesemodules, but there is also
conservation of residues that contributes to the interface with
the next module. In addition, six of seven DAF CCP 2 residues
critical for function are conserved in FH CCP 1, some of which
(Arg-53, Lys-82, and Arg-83) correspond also to interface resi-
dues. Indeed, there is resemblance between electrostatic sur-
face representations of FH CCP 1 and DAF CCP 2 (Fig. 5). A
smaller set of functionally critical residues is conserved, and a
lesser degree of electrostatic resemblance is evident when FH
CCP 1 is compared with CR1 CCP 15. In contrast, there is no
conservation of functionally critical residues and poor back-
bone overlay when comparing FH CCP 1 with CCP 1 or CCP 2
of MCP.
FIGURE 6. Differences in chemical shifts arising from substitutions of amino acid residues in FH1-2. Combined (1H,15N) chemical shift difference (	

((	NH)2  (	15N/5)2)) from amino acid residue substitutions, FH1-2(H53) (A) and FH1-2(I62) (C). Mapping of the largest chemical shift perturbation of
amides (	 0.04 ppm) for FH1-2(H53) (B) and for FH1-2 (I62) (D) onto the closest to mean FH1-2 structure shown as schematics (PyMol) with the side chain
of the relevant residue highlighted. The sphere radius of the HN atom is proportional to the magnitude of chemical shift perturbation.
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There is a close resemblance at the backbone level between
the secondmodule of FH and the secondmodules of functional
sites in the other regulators, CR1 CCP 16, DAF CCP 3, and
C4BP CCP 2 (Table 2). Despite their conserved structural
framework, inspection of the electrostatic surface representa-
tions of these DAF and FH modules does not reveal obvious
similarities (Fig. 5). Furthermore, residues identified as func-
tionally critical in DAF CCP 3, e.g. Phe-169 and Leu-171 (74),
are not conserved in FH CCP 2.
In addition to its resemblance to FB CCP 3, the third FH
module also shares a highly similar (C r.m.s.d. 1.6 Å) back-
bone structure with the third CCP of the DAF functional site
(i.e. DAF CCP 4). The resemblance is less marked, however,
when comparing FH CCP 3 to CR1 CCP 17 (C r.m.s.d.  2.1
Å). Two of three DAF CCP 4 residues that were identified as
important in mutagenesis studies are conserved in FH CCP 3
(Fig. 1). Surprisingly, there was relatively little obvious struc-
tural similarity between CCPs 1, 2, or 3 of FH andmodules 1, 2,
or 3 of VCP, respectively, despite high percentage sequence
identity.
Implications of Structural Similarities among CCPs for Func-
tional Properties—That theN-terminalmodules of FHandCR1
and the second module of DAF (all of which form parts of sites
with decay accelerating activity),
but not the equivalent module of
MCP (that does not have decay
accelerating activity), share back-
bone and surface similarities sug-
gests they recognize the same sub-
site within the C3b,Bb complex.
This is likely to be the von Will-
ebrand factor type A domain of Bb
(75). The subsequent two modules
within the decay accelerators are
arranged in a similar way with
respect to the first modules of their
respective triple-module functional
units (Fig. 4, A–F). Assuming these
intermodular arrangements are
preserved in the complex, it follows
that FH CCP 2, CR1 CCP 16, and
DAF CCP 3 would be positioned in
similar orientations and locations
relative to the convertase surface.
But the fact that these modules,
although highly similar in their
backbone structures, differ in their
surface properties implies they are
unlikely to make equivalent interac-
tions with the convertase. Indeed,
the functionally critical surface
hydrophobic patch present on DAF
CCP3 (74) does not occur anywhere
on the surface of FH CCP 2. This
observation is consistent with the
suggestion of Harris et al. (75) that
the bulk of DAF CCP 3 acts primar-
ily as a spacer. Thus, the second
modules of FH and CR1 site 2 could play a similar role with
respect to their decay acceleration properties but might have
the additional job of recruiting FI to the complex. The fourth
DAF module was proposed to interact weakly with C3b (74)
once DAFCCP 2 has docked onto Bb; FHCCP 3 and, to a lesser
extent, CR1 CCP 17 are likely to be functionally equivalent to
DAF CCP 4 since they all share a similar structure and two of
three functionally critical residues in DAFCCP 4 are conserved
in FH CCP 3 and CR1 CCP 17. Thus, structural comparisons
support a common mechanism of decay acceleration among
these three RCAs inwhich separate binding sites in the first and
third modules, for C3b and Bb, are so-positioned by the middle
module that they bind to and stabilize an intermediate on the
pathway to convertase dissociation.We are in aweaker position
to speculate about cofactor activity due to the more limited
nature of the structural comparison we can make with MCP.
The different architecture of VCP indicates that it has evolved
an alternative mechanism for decay acceleration.
Disease-linked Sequence Variations—Thus, the firstmodules
within decay acceleration sites on RCAs are inferred to perform
the common role of binding to factor Bb of the C3 convertase.
Mutations and sequence variations in FH CCP 1, therefore,
have the capacity to modulate its decay accelerating activity.
FIGURE 7. Residueswhose amide shifts aremost affected by the R53Hmutation. A, schematic-type repre-
sentation focusing on the CCP 1- CCP 2 interface of FH1-2 (closest-to-mean structure), oriented as in Fig. 2C. Resi-
duesexhibitingcombinedamidechemical shift differences0.1ppm(inFH1-2(H53)versuswild type) are shown in
space-fill representation and colored blue-green. Residues in CCP 2 exhibiting combined amide chemical shift dif-
ferences0.04 ppm are shown in space-fill representation and colored light blue. The side chain of the substi-
tuted residue, Arg-53, is drawn as sticks, and its atomic surface is represented as dots. B, the same as A but
rotated by 45° about the y axis. C andD, the same views as in A and B but showing amodel of FH1-2(H53). The
color scheme is as before except His53 is colored pink.
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The mutation R53H in FH CCP 1 corresponds to a conserved
DAF CCP 2 residue (Arg-96) that is important for decay accel-
erating activity according to DAF mutagenesis (74, 76) and is
also conserved in CR1 CCP 15 as Arg-933. NMR studies and
molecular modeling (Fig. 7) show His-53 can replace Arg-53 in
FH without loss of CCP 1 structural integrity. The R53Hmuta-
tion, however, results in chemical shift perturbations among
nearby residues, implying a possible effect on local structure,
and this is consistent with the fact that the alkyl part of the
Arg-53 side chain is largely buried. There are also chemical shift
changes in CCP 2 relative to the wild type, presumably due to
the close association of the Arg-53, or His-53, side chain with
interface-critical residue Tyr-56 that makes hydrophobic con-
tacts with Tyr-106 in CCP 2 (Fig. 7); thus, we cannot rule out a
small mutation-induced rearrangement of the modules. This
mutant is thermally less stable than wild type, and indeed there
is some spectral evidence for a slight deterioration of the struc-
ture of the mutant at temperatures just above 37 °C. Taken
together with the probable loss of charge resulting from
replacement of positively charged arginine with histidine (at
physiological pH) and, hence, the disturbance of an electro-
static surface that is common to C3b-engaging DAF and FH
modules, these results are consistent with a detrimental effect
of the Arg-53 to His mutation on the decay accelerating capa-
bilities of FH. Thus, the presence of amutation in a patient with
aHUS is probably not coincidental even though most other
mutations linked to this disease occur in FH CCPs 19 and 20
and disrupt other aspects of FH function. On the other hand,
the single nucleotide polymorphism in FH corresponding to
V62I seems unlikely to have any consequences for the ability of
FH to regulate complement. The Ile-62 allotype of FH1-2
appears slightlymore thermally stable and rigid than theVal-62
version, so it is conceivable that its potentially protective roles
in AMD and DDD arise from a more robust nature of the full-
length protein within a physiological setting, but this would
require further investigation.
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